Benebiose: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Benebiose
Largest movements
- Receivables within one year -€1,273
down €1,273 (-98.6%), from €1,291 to €18
of which Trade receivables: -€1,262
- Cash +€178
up €178 (+8.6%), from €2,081 to €2,259
mainly Other debts (+€3,711) and Receivables within one year (+€1,273)
- Trade debts -€4,227
down €4,227 (-100.0%), from €4,227 to €0
- Other debts +€3,711
up €3,711 (+49.6%), from €7,487 to €11,198
- Profit (loss) carried forward -€566
down €566 (-0.2%), from -€237,667 to -€238,232
- Gross operating margin +€14,491
up €14,491, from -€14,260 to €231
- Other operating charges -€182
down €182 (-30.8%), from €592 to €409
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,047 | €2,966 | -€1,081 | -26.7% |
| Current assets | 29/58 | €4,047 | €2,966 | -€1,081 | -26.7% |
| Amounts receivable within one year | 40/41 | €1,291 | €18 | -€1,273 | -98.6% |
| Trade receivables | 40 | €1,262 | €0 | -€1,262 | -100.0% |
| Other amounts receivable | 41 | €29 | €18 | -€11 | -38.8% |
| Cash at bank and in hand | 54/58 | €2,081 | €2,259 | +€178 | +8.6% |
| Deferred charges and accrued income | 490/1 | €675 | €689 | +€13 | +2.0% |
| Total equity and liabilities | 10/49 | €4,047 | €2,966 | -€1,081 | -26.7% |
| Equity | 10/15 | -€7,667 | -€8,232 | -€566 | -7.4% |
| Contributions | 10/11 | €230,000 | €230,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€237,667 | -€238,232 | -€566 | -0.2% |
| Amounts payable | 17/49 | €11,714 | €11,198 | -€516 | -4.4% |
| Amounts payable within one year | 42/48 | €11,714 | €11,198 | -€516 | -4.4% |
| Trade debts | 44 | €4,227 | €0 | -€4,227 | -100.0% |
| Suppliers | 440/4 | €4,227 | €0 | -€4,227 | -100.0% |
| Other amounts payable | 47/48 | €7,487 | €11,198 | +€3,711 | +49.6% |
| Non-recurring operating income | 76A | - | €2,088 | +€2,088 | |
| Other operating charges | 640/8 | €592 | €409 | -€182 | -30.8% |
| Gross operating margin | 9900 | -€14,260 | €231 | +€14,491 | |
| Operating profit (loss) | 9901 | -€14,852 | -€178 | +€14,674 | +98.8% |
| Financial charges | 65/66B | €292 | €388 | +€95 | +32.6% |
| Recurring financial charges | 65 | €292 | €388 | +€95 | +32.6% |
| Profit (loss) for the period before taxes | 9903 | -€15,144 | -€566 | +€14,578 | +96.3% |
| Profit (loss) for the period | 9904 | -€15,144 | -€566 | +€14,578 | +96.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€15,144 | -€566 | +€14,578 | +96.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.